Michael D. Clayman
2016
In 2016, Michael D. Clayman earned a total compensation of $6.9M as President, Chief Executive Officer and Co-Founder at Flexion Therapeutics, a 114% increase compared to previous year.
Compensation breakdown
| Bonus | $330,528 |
|---|---|
| Option Awards | $6,069,000 |
| Salary | $500,800 |
| Other | $22,297 |
| Total | $6,922,625 |
Clayman received $6.1M in option awards, accounting for 88% of the total pay in 2016.
Clayman also received $330.5K in bonus, $500.8K in salary and $22.3K in other compensation.
Rankings
In 2016, Michael D. Clayman's compensation ranked 961st out of 14,075 executives tracked by ExecPay. In other words, Clayman earned more than 93.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 961 out of 14,075 | 93rd |
Division Manufacturing | 318 out of 5,489 | 94th |
Major group Chemicals And Allied Products | 82 out of 1,895 | 96th |
Industry group Drugs | 54 out of 1,538 | 97th |
Industry Pharmaceutical Preparations | 46 out of 1,176 | 96th |
Source: SEC filing on April 28, 2017.
Clayman's colleagues
We found two more compensation records of executives who worked with Michael D. Clayman at Flexion Therapeutics in 2016.